- ￥3000
- Biosearch Technologies
- SMF-HB1-10
- 2025年07月14日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 库存：
1
- 供应商：
上海玉博生物科技有限公司
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验10s to 100s of genetic targets across 100s to 1000s of samples. Cancer gene mutation profiling, with its select roster of candidate oncogenes and tumor suppressors, can be readily assessed on the MassARRAY® system. The MassARRAY®
Developing Genetically Engineered Mouse Models to Study Tumor Suppression
and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr. Biol. 8:1169‐1178. Sztein, J.M., Farley, J.S., and Mobraaten, L.E. 2000. In vitro
.（5）结果UT-PCR和PCR-RFLP的检测结果与DNA测序结果的符合率均为98.11%。（6）Results of the analysis of DNA sequence approved that the hc γ1 gene fuse with HCV E1 + E2661 or E2661 were cloned into the recombinant plasmids successfully.（6）DNA测序结果证实插入片段即是HCV E1+E2661及E2661与HC γ1的融合
技术资料暂无技术资料 索取技术资料
